Artelo Biosciences
Price & Volume
Stats
See moreOpen | $1.32 |
Previous Close | $1.36 |
Day Range | $1.32-$1.54 |
52W Range | $1.19-$85.80 |
Market Cap | $2.9M |
Shares Short | 62,523 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$29.01 |
News
See moreYahoo Finance • last month
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
Yahoo Finance • 2 months ago
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Yahoo Finance • 2 months ago
Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength
Yahoo Finance • 2 months ago
Biotech Breakthroughs and Strategic Pivots Fuel Market Momentum
About
CEO | Mr. Gregory D. Gorgas M.B.A. |
CFO | Mr. Mark E. Spring CPA |
Address | 505 Lomas Santa Fe, Solana Beach, CA, United States, 92075 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |